Status:
NOT_YET_RECRUITING
Evaluation of the Effect of Healthy Lifestyle Intervention for Patients With Mild Cognitive Impairment
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Mild Cognitive Impairment (MCI)
Eligibility:
All Genders
Phase:
NA
Brief Summary
This clinical study aims to evaluate the feasibility and preliminary effectiveness of a comprehensive lifestyle intervention program for patients with mild cognitive impairment. The intervention consi...
Detailed Description
Research Background 1. MCI Status and Impact Mild Cognitive Impairment (MCI) is an intermediate state between normal aging and dementia, characterized by cognitive decline. Globally, the prevalence o...
Eligibility Criteria
Inclusion
- To meet the diagnostic criteria of MCI, refer to the diagnostic criteria of MCI in "2018 Chinese Guidelines for the Diagnosis and Treatment of Dementia and Cognitive Impairment (5) : Diagnosis and Treatment of Mild Cognitive Impairment".
- Have caregiver \> 6 months.
- Participate in the study voluntarily and sign the informed consent.
Exclusion
- Have received other cognitive intervention therapy recently (within 6 months).
- Diagnosis of functional encephalopathy or obvious mental disorders, such as Parkinson's disease, epilepsy, schizophrenia.
- Suffering from serious cardiovascular diseases, malignant tumors and other major physical diseases.
- Have visual, hearing, speech or limb dysfunction, unable to complete the test.
- Patients with chronic diseases who have special dietary needs or require special dietary management.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06942780
Start Date
May 1 2025
End Date
August 1 2025
Last Update
May 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital, Capital Medical University
Beijing, China, 100053